Quercetin Effect on Post-ceserean Pain
Launched by FUTURE UNIVERSITY IN EGYPT · Oct 18, 2024
Trial Information
Current as of May 30, 2025
Completed
Keywords
ClinConnect Summary
The cesarean section is a common gynecological surgery, accounting for 40-50% of deliveries in public hospitals. Effective pain management following a cesarean delivery is crucial, as inadequate control can hinder a mother's capacity to care for her newborn. Uncontrolled postoperative pain can lead to patient immobility, increasing the risk of thromboembolic complications. Failure to adequately manage pain can result in economic and medical issues, including longer hospital stays, higher readmission rates, increased patient recovery costs, and patient dissatisfaction with the quality of hea...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Referred to elective (non-emergency) cesarean section
- • Undergoing spinal anesthesia) with American Society of Anesthesiologists (ASA) classification I and II
- • Term gestational age
- Exclusion Criteria:
- • History of seizures
- • Pre-eclampsia or eclampsia
- • Hypertension
- • Use of narcotic painkillers for 24 h before the intervention
- • Medications inducing neuropathy including Amiodarone, Metronidazole, Phenytoin \& Colchicine.
- • Prolongation of cesarean section (more than 1.5 h)
- • Increase in the size of the incision
- • Occurrence of any unusual complication during surgery,
- • Failure of spinal anesthesia and its conversion to general anesthesia
- • Contraindications to spinal anesthesia
- • Use of interacting medication: fluoroquinolones, loratadine, fexofenadine, alvimopan, armodafinil
About Future University In Egypt
Future University in Egypt is a leading academic institution dedicated to advancing medical research and education. As a clinical trial sponsor, the university focuses on innovative studies that aim to enhance healthcare outcomes and address pressing medical challenges. With a commitment to ethical standards and scientific rigor, Future University collaborates with healthcare professionals and researchers to facilitate evidence-based practices and contribute to the global body of medical knowledge. Its strategic initiatives aim to foster a culture of research excellence, ultimately benefiting both local and international communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported